Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by ACSL4 is an isozyme of the long-chain fatty-acid-coenzyme A ligase family.
Showing 10 out of 102 products:
Human Polyclonal ACSL4 Primary Antibody pour IF, IHC (p) - ABIN389113
Rodriguez, Bhat, Meloni, Ladd, Leslie, Doyne, Renieri, Dupont, Stevenson, Schwartz, Srivastava: Intellectual disability, midface hypoplasia, facial hypotonia, and Alport syndrome are associated with a deletion in Xq22.3. dans American journal of medical genetics. Part A 2010
Show all 8 Pubmed References
Human Polyclonal ACSL4 Primary Antibody pour ELISA, WB - ABIN268614
Piccini, Vitelli, Bruttini, Pober, Jonsson, Villanova, Zollo, Borsani, Ballabio, Renieri: FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. dans Genomics 1998
Study demonstrated that ACSL4 was overexpressed in HCC (Montrer FAM126A Anticorps).
These results suggest that ACSL1 (Montrer Acsl1 Anticorps), ACSL4 and ACSL5 (Montrer ACSL5 Anticorps) expression is regulated by ER signaling pathways and ACSL5 (Montrer ACSL5 Anticorps) is a potential novel biomarker for predicting prognosis of breast cancer patients.
studies have identified a novel substrate-induced posttranslational regulatory mechanism by which AA downregulates ACSL4 protein expression in hepatic cells.
Data show that ELOVL7 (Montrer ELOVL7 Anticorps), SOCS3 (Montrer SOCS3 Anticorps), ACSL4 and CLU (Montrer CLU Anticorps) were upregulated while PRKAR1A (Montrer PRKAR1A Anticorps) and ABCG1 (Montrer ABCG1 Anticorps) were downregulated in the phlegm-dampness group.
ACSL4 is not only a sensitive monitor of ferroptosis, but also an important contributor of ferroptosis.
ACLS4 and ACLS3 have roles in insulin (Montrer INS Anticorps) secretion
Silencing of ACSL4 eliminated the 17beta-estradiol-induced increase in AA and EPA uptake.
ACSL4 plays a tumor-suppressive role in gastric cancer.
Suggest role for ACSL4 expression in development of castration-resistant prostate cancer.
we demonstrate that ACSL4 can be considered a novel activator of the mTOR (Montrer FRAP1 Anticorps) pathway
Report PPARdelta (Montrer PPARD Anticorps)-mediated regulatory mechanism for ACSL4 expression in liver tissue and cultured hepatic cells.
Sequence analysis of a 1.5-kb fragment of the Acsl4 promoter revealed the absence of a TATA box and the presence of many putative binding sites for transcription factors including Sp1 (Montrer SP1 Anticorps) and CREB (Montrer CREB1 Anticorps).
Acsl4 is a phosphoprotein whose phosphorylation is hormone-dependent.
These results indicate that the ACS4 protein specifically expressed in brain plays an important role in arachidonate metabolism and neuronal differentiation in the brain.
the involvement of SHP2 (Montrer PTPN11 Anticorps) activity in the regulation of the expression of the fatty acid-metabolizing enzyme ACSL4
Results indicate that fatty acid binding protein H-FABP (Montrer FABP3 Anticorps) and CoA ligase 4 ACSL4 genes might serve as markers to improve fat (IMF (Montrer MDFI Anticorps)) content in the breeding system.
ACSL4 Single Nucleotide Polymorphism G2645A is associated with several meat quality traits.
Polymorphisms within the ACSL4 gene are associated with growth and meat quality.
The analyses of mutant lines revealed strongly overlapping functions of LACS4 and LACS9 in lipid trafficking from the endoplasmic reticulum to the plastid.
The combined inactivation of LACS1 (Montrer Acsl1 Anticorps) and LACS4 in Arabidopsis resulted in conditional pollen sterility and impaired wax biosynthesis.
The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the mental retardation or Alport syndrome. Alternative splicing of this gene generates 2 transcript variants.
acyl-CoA synthetase long-chain family member 4
, long-chain-fatty-acid--CoA ligase 4
, Long-chain-fatty-acid--CoA ligase 4
, long-chain-fatty-acid--CoA ligase 4-like
, LACS 4
, acyl-CoA synthetase 4
, fatty-acid-Coenzyme A ligase, long-chain 4
, lignoceroyl-CoA synthase
, long-chain acyl-CoA synthetase 4
, long-chain fatty-acid-Coenzyme A ligase 4
, fatty acid-Coenzyme A ligase, long chain 4
, fatty acid Coenzyme A ligase, long chain 4
, fatty acid-Coenzyme A ligase long chain 4
, acyl-CoA synthetase long-chain family member 3